Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRN1005 for Brain Metastases from Breast or Lung Cancer
NCT01679743Phase 2Withdrawn
- Sponsor
- National Cancer Institute
- Start
- Aug 2012
- Primary completion
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptide-Drug Conjugates
01
Overview
A Phase 2 trial of paclitaxel trevatide in brain metastases, sponsored by National Cancer Institute. Planned start Aug 2012; status: withdrawn.
02
Drugs
paclitaxel trevatide
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT01679743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01679743.